A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.
Ann Oncol
; 24(10): 2601-2606, 2013 Oct.
Article
in En
| MEDLINE
| ID: mdl-23857959
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Naphthoquinones
/
Carcinoma, Non-Small-Cell Lung
/
Inhibitor of Apoptosis Proteins
/
Imidazoles
/
Lung Neoplasms
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2013
Document type:
Article
Country of publication:
United kingdom